https://www.fortunebusinessinsights.com/industry-reports/alzheimers-drugs-market-101033

Alzheimer’s Drugs Market Demand, Drivers,
and Forecast Trends
Alzheimer’s drugs market is steadily expanding as the global incidence of Alzheimer’s disease—characterized
by cognitive decline and memory loss—continues to rise alongside aging populations. While traditional
therapies like cholinesterase inhibitors and NMDA antagonists remain foundational for symptom
management, the market is also witnessing growing interest in emerging disease-modifying treatments,
such as monoclonal antibodies targeting amyloid and tau proteins.
According to Fortune Business Insights, the global Alzheimer’s drugs market was valued at USD 3.52 billion
in 2022 and is projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a
CAGR of 5.1% during the forecast period. In 2022, North America dominated the Alzheimer’s drugs market
with a market share of 51.42%.